
LOTTE HOLDINGS Japan Invests in Elixiron Immunotherapeutics
TOKYO, JAPAN, June 19, 2025 /EINPresswire.com/ -- LOTTE HOLDINGS CO., LTD. (Headquarter: Tokyo, Japan, President and CEO: Genichi Tamatsuka, hereinafter “LOTTE HOLDINGS”) is pleased to announce a strategic investment in the Series B-2 of Elixiron …